Wednesday, June 19, 2013
Submit a News Story
ImmunoCellular Therapeutics’ Investigational New Drug Application for ICT-140 Allowed by the FDA
Published: Wednesday, January 30, 2013
Last Updated: Wednesday, January 30, 2013
Investigational new drug (IND) application for ICT-140 paves the way for conducting a clinical trial.
Full access to this article is for registered users only.
is free-of-charge and allows access to all content on our web communities.
Already registered? Then please log in at the top of the page.
Expelled DNA that Traps Toxins May Backfire in Obese
The body’s most powerful immune cells may have a radical way of catching their prey that could backfire on people who are overweight.
Developmental Protein Plays Role in Spread of Cancer
A protein used by embryo cells during early development, and recently found in many different types of cancer, apparently serves as a switch regulating metastasis.
Experimental Vaccine Shows Promise against TB Meningitis
Study in animals lays groundwork for new prevention strategies in brain TB.
Circuitry of Cells Involved in Immunity, Autoimmune Diseases Exposed
Connections point to interplay between salt and genetic factors.
Genetically Modified Stem Cells are Effective Against Acute Respiratory Diseases
Administration of genetically modified mesenchymal stem cells regenerates lung tissue and stops the inflammatory process in mice with acute lung injury.
Producing Reliable Quantitative Western Blot Data
The reporting of fold changes in protein expression from western blots is often viewed with skepticism due to questions about the validity of the technique as a quantitative method.
Researchers Pioneer Treatment for Viral Infection Common in Children
Professor Peter Openshaw and team develops a new technique used in tackling a wide range of other diseases.
Big Multiple Sclerosis Breakthrough
Phase 1 trial safely resets patients’ immune systems, reduces attack on myelin protein.
BACH2 Helps Orchestrate the Immune Response
A gene called BACH2 may affect the development of MS, asthma, Crohn's disease, celiac disease and other allergic and autoimmune diseases.
TB Bacteria's Trash-Eating Inspires Search for New Drugs
When hijacking a garbage truck, one might as well make use of the trash. That logic drives how tuberculosis-causing bacteria feed, say Cornell scientists.
Advertise On This Site
Terms & Conditions
©2013 Technology Networks
, all rights reserved.